Abstract
Background and Objectives
Injecting various blood products has potential risks for trauma patients. This study was conducted with the aim of determining the amount of blood product injection in the treatment of patients with acute trauma who referred to the Besat Medical Training Center in Hamedan in 2018-2019.
Materials and Methods
This cross-sectional study was conducted on the records of 227 trauma patients admitted to Besat Hospital in Hamadan during 2018-2019 based on the rate of their transfusion the rate of transfusions. The study data were analyzed with SPSS23 and appropriate non-parametric tests such as Mann-Whitney, Kruskal-Wallis and Spearman's correlation test. The significance level in all tests was considered <0.05.
Results
In this study, the most common types of trauma and mechanism were penetrating (65.2%) and traffic accidents (70%); 62.1% of the damaged organs pertained to head and neck areas and 72.7% of the cases required surgery with 18.1% mortality. The frequency rates of administered units of PRBC) 4.70 ± 5.10(, platelets )0.72 ± 1.37(, and FFP )1.98 ± 2.67( were significantly higher in trauma patients who died and required surgery (P< 0.05). The mean and standard deviation of the patients' age was 45.63 ± 19 years; 67.40% of patients were male.
Conclusions
In trauma patients who underwent surgery and died due to head and neck trauma, the frequency of packed red blood cells, platelets and FFP injection and the mortality rate was significantly higher than other trauma patients. Optimal use of blood products in accordance with the updated guidelines is recommended.